Biomaterials in Obstetrics and Gynecology - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 163

3. Speroff L. 2005. Intrauterine device (IUD). In Clinical Gynecologic Endocrinology
and Infertility 7th edition. Speroff L, et al., eds. Lippincott Williams and Wilkins.
4. Gamble CJ. 1957. Spermicidal times as aids to the clinician's choice of contracep-
tive materials. Fertile Steril 8: 174.
5. Stubblefield PG, Carr-Ellis S, Kapp N. Family planning . In Berek and Novak's
Gynecology 14th edition, pp. 247-312. Lippincott, Williams and Wilkins.
6. www.essure.com
7. www.adiana.com
8. Palmer SN, Greenberg JA. 2009. Transcervical sterilization: A comparison of
Essure ® Permanent Birth Control System and Adiana ® Permanent Contraception
System . Rev Obstet Gynecol 2(2): 84-92.
9. Kumar S. 2009. Intra-peritoneal prophylactic agents for preventing adhesions
and adhesive intestinal obstruction after non-gynaecological abdominal surgery.
Cochrane Database Syst Rev .
10. Ahmad G. 2010. Barrier agents for adhesion prevention after gynecological sur-
gery. Cochrane Database Syst Rev .
11. Pados G. 2010. Prevention of intra-peritoneal adhesions in gynecological surgery:
Theory and evidence. Reproductive BioMedicine 21: 290-303.
12. DeChemey AH. 2010. Preventing postoperative peritoneal adhesions. UpToDate .
13. Monk BJ. 1994. Adhesions after extensive gynecologic surgery: Clinical signifi-
cance, etiology, and prevention. Am J Obstet Gynecol 170(5 Pt 1): 1396-1403.
14. Holmdahl L. 1997. Adhesions. Pathogenesis and Prevention. Panel discussion
and summary. Department of Surgery, Ostra Hospital, University of Göteborg,
Sweden.
15. Lundorf P, J Donnez, M Korell, AJ Audeburt, K Block, GS diZegega. 2005.
Clinical evaluation of a viscoelastic gel for reduction of adhesions following a
gynaecological surgery by laparoscopy in Europe. Human Reproduction 20(2):
514-520.
16. Young P, A Johns, C Templeman, C Witz, B Webster, R Ferland, M Diamond, K
Block, GS diZerega. 2005. Reduction of postoperative adhesions after laparo-
scopic gynaecological surgery with oxiplex/AP gel: A pilot study. Fertility and
Sterility 845: 1450-1456.
17. Koren G. 2007. Medication safety. In Pregnancy and Breastfeeding .
18. Erin E. 2005. Maternal hair dye use and risk of neuroblastoma in offspring.
Cancer Causes and Control 16: 743-748.
19. Bondurant S. 1999. Safety of Silicone Breast Implants . Chapter 11 (pp. 248-263).
20. ACOG Practice Bulletin Number 107. 2009. Induction of labor. Obstet. Gynecol
114 (2) Part 1: 386-397.
21. Shveiky D, Shushan A, Ben Bassat H, Klein BY, Ben Meir A, Levitzky R, Rojansky
N. 2009. Acetaldehyde differentially affects the growth of uterine leiomyomata
and myometrial cells in tissue cultures. Fertil Steril Feb 91(2): 575-79.
22. Shveiky D, Rojansky N, Ben Bassat H, Ben Meir A, Klein B, Shushan A. 2009.
Family history of uterine fibroids associated with low level of fumarate hydra-
tase in leiomyomata cells. Eur J Obstet Gynecol Reprod Biol 146(2): 234-35.
23. Goodwin SC, Spies JB. 2009. Uterine fibroid embolization. N Engl J Med Aug
361(7): 690-97.
24. Bloom AI, Verstandig A, Gielchinsky Y, Nadiari M, Elchalal U. 2004. Arterial
embolisation for persistent primary postpartum haemorrhage: Before or after
hysterectomy ? BJOG. 111(8): 880-84.